Get the Stockscreener App
12.12
4.25%
0.485
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Perrigo Company Plc stock is traded at $12.12, with a volume of 850.57K.
It is up +4.25% in the last 24 hours and up +14.59% over the past month.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
See More
Previous Close:
$11.64
Open:
$12.27
24h Volume:
850.57K
Relative Volume:
0.27
Market Cap:
$1.66B
Revenue:
$4.25B
Net Income/Loss:
$-1.40B
P/E Ratio:
-1.1798
EPS:
-10.2775
Net Cash Flow:
$143.60M
1W Performance:
+7.48%
1M Performance:
+14.59%
6M Performance:
-18.72%
1Y Performance:
-50.83%
1-Day Range:
$11.60
$12.58
1-Week Range:
$11.31
$12.58
52-Week Range:
$9.225
$28.43
Perrigo Company Plc Stock (PRGO) Company Profile
Name
Perrigo Company Plc
Sector
Phone
269-673-8451
Address
THE SHARP BUILDING, DUBLIN 2
Compare PRGO vs TAK, ZTS, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRGO
Perrigo Company Plc
|
12.09 | 1.60B | 4.25B | -1.40B | 143.60M | -10.28 |
TAK
Takeda Pharmaceutical Co Adr
|
16.64 | 52.28B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.05 | 47.33B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.77 | 41.76B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.70B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
590.00 | 24.28B | 3.18B | 1.33B | 1.04B | 27.90 |
Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-14-25 | Downgrade | Argus | Buy → Hold |
| Jan-06-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-24-24 | Resumed | Jefferies | Hold |
| Nov-17-23 | Initiated | Piper Sandler | Overweight |
| Mar-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-14-22 | Upgrade | Argus | Hold → Buy |
| Sep-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-14-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-30-21 | Upgrade | Jefferies | Hold → Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Jan-06-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-17-20 | Downgrade | Argus | Buy → Hold |
| Mar-24-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-20-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-18-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-11-19 | Upgrade | Argus | Hold → Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Nov-13-18 | Downgrade | Berenberg | Buy → Hold |
| Aug-10-18 | Reiterated | Stifel | Hold |
| Jul-30-18 | Downgrade | Argus | Buy → Hold |
| Jul-12-18 | Downgrade | Goldman | Neutral → Sell |
| Jan-03-18 | Initiated | Leerink Partners | Mkt Perform |
| Dec-08-17 | Upgrade | Argus | Hold → Buy |
| Nov-10-17 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Oct-05-17 | Reiterated | UBS | Buy |
| Sep-07-17 | Initiated | Oppenheimer | Outperform |
| Aug-11-17 | Upgrade | Goldman | Sell → Neutral |
| Aug-11-17 | Reiterated | RBC Capital Mkts | Underperform |
| Jun-16-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-05-17 | Downgrade | RBC Capital Mkts | Sector Perform → Underperform |
| Mar-03-17 | Reiterated | B. Riley & Co. | Neutral |
View All
Perrigo Company Plc Stock (PRGO) Latest News
Perrigo stock gains nearly 5% on earnings beat despite revenue miss - Investing.com Nigeria
Perrigo (NYSE:PRGO) Releases FY 2026 Earnings Guidance - MarketBeat
Earnings Flash (PRGO) Perrigo Company plc Reports Q1 Revenue $969.2M, vs. FactSet Est of $1.04B - marketscreener.com
Earnings Flash (PRGO) Perrigo Company plc Posts Q1 Adjusted EPS $0.43 per Share, vs. FactSet Est of $0.31 - marketscreener.com
Perrigo: Q1 Earnings Snapshot - marketscreener.com
Major goodwill hit drives Perrigo (NYSE: PRGO) Q1 2026 loss as it keeps 2026 EPS outlook - Stock Titan
Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations - PR Newswire
Infant Formula Probes And ESOP Share Filing Might Change The Case For Investing In Perrigo (PRGO) - simplywall.st
How Investors Are Reacting To Perrigo (PRGO) Dermacosmetics Sale, Dividend Payout, And Infant Formula Strains - Yahoo Finance
Perrigo Shareholders Endorse Directors, Pay and Capital Flexibility - TipRanks
Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch
Perrigo (PRGO) investors back 2026 incentive plan and elect board - Stock Titan
Perrigo earnings ahead: Can cost savings counter portfolio reset? By Investing.com - Investing.com Australia
Perrigo earnings ahead: Can cost savings counter portfolio reset? - Investing.com
MSN Money - MSN
Perrigo Co. PLC stock underperforms Monday when compared to competitors - MarketWatch
Perrigo Company (PRGO) Q1 2026 Preview: EPS Est. $0.31, Reports May 6 - AlphaStreet
Rizwan Mir | ChicagoCISO ORBIE® Awards - Crain's Chicago Business
Perrigo Company plc (NYSE: PRGO) Long Term Investor Alert: Investigation of potential Wrongdoing - openPR.com
Perrigo Dermacosmetics Sale Tests Focused Self Care And Debt Reduction - Sahm
Short Interest in Perrigo Company plc (NYSE:PRGO) Drops By 16.6% - MarketBeat
Perrigo Completes Divestiture of Dermacosmetics Business - GuruFocus
Perrigo completes sale of dermacosmetics unit for €332.6m By Investing.com - Investing.com India
Perrigo completes sale of dermacosmetics unit for €332.6m - Investing.com UK
Perrigo (NYSE: PRGO) nets €305.6M upfront from Dermacosmetics sale - Stock Titan
FDA says U.S. baby formula supplies are safe (ABT:NYSE) - Seeking Alpha
Perrigo Q2 2025 Earnings Preview - MSN
Understanding the Setup: (PRGO) and Scalable Risk - Stock Traders Daily
Perrigo Co. PLC stock underperforms Wednesday when compared to competitors - MarketWatch
Perrigo Company plc Announces Quarterly Dividend of $0.29 (NYSE:PRGO) - MarketBeat
Perrigo Announces Quarterly Dividend - StreetInsider
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Perrigo declares $0.29 quarterly dividend, payable June 16 By Investing.com - Investing.com South Africa
Perrigo declares $0.29 quarterly dividend, payable June 16 - Investing.com
Zacks Research Forecasts Perrigo's Q2 Earnings (NYSE:PRGO) - MarketBeat
Perrigo (NYSE:PRGO) Stock Rating Upgraded by Zacks Research - MarketBeat
Perrigo (PRGO) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Perrigo to Buy Elan for $8.6 Billion - AOL.com
3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now - AOL.com
3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now - The Motley Fool
Perrigo Company plc announces Quarterly dividend, payable on June 16, 2026 - marketscreener.com
Vanguard Portfolio Management (PRGO) owns 8.25M shares, 5.99% stake - Stock Titan
[SCHEDULE 13G] PERRIGO Co plc Passive Investment Disclosure (>5%) - Stock Titan
Perrigo: Positioning Through A Thesis Reset (PRGO) - Seeking Alpha
Is Perrigo (PRGO) Offering Value After A 49.9% One Year Share Price Decline? - Yahoo Finance
Perrigo gains amid takeover speculation - MSN
Perrigo Co. PLC stock underperforms Thursday when compared to competitors - MarketWatch
Why Did Perrigo Stock Tumble 9% Pre-Market Today? - MSN
Perrigo Company Plc Stock (PRGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):